DiscoverNew Retina Radio by EyetubeAAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD
AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

Update: 2024-11-07
Share

Description

The ELEVATUM study exclusively enrolled historically underrepresented patients in a study assessing faricimab (Vabysmo, Genentech/Roche) for DME. Were there any surprises in the data? Jeremiah Brown, MD, MS, sits down with New Retina Radio to review the philosophy behind the ELEVATUM study, discuss the study’s findings, and preview the next phases of the trial. And Eric Schneider, MD, joins the program to discuss the findings of a pivotal study assessing home OCT (Scanly, Notal Vision) in wet AMD patients. Is home OCT equivalent to in-office OCT when it comes to visualization? And do expert graders agree with an AI algorithm’s assessments of patient’s pathology?

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

Retina Today

We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and our services, you agree to our use of cookies as described in our Cookie Policy.